HIG Capital exits Celerion in $1.8bn sale
Tuesday, June 16, 2026 · first reported by Private Equity Wire
HIG Capital completed $1.8bn sale of clinical research organization Celerion to THL Partners funds, marking Advantage fund realization.
- Firm
- HIG Capital
- Also named
- THL Partners, Celerion Holdings
- Fund
- Advantage
- Deal value
- $1.8B
- Asset class
- Private equity
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 sourceMore on HIG Capital
Everything on this firm →- Antin agrees sale of majority stake in Vicinity Energy to Harrison StreetPrivate Equity Wire +3
- CPP Investments sells A$4.5bn Australian toll road stakes to TransurbanIPE Real Assets
- Sycamore nears $9bn sale of Boots to Weston familyPrivate Equity Wire
- Eagle Point backs $450m US government-leased real estate recapitalisationIPE Real Assets
- CSC acquires 50% Watergardens mall stake from QIC for A$480mIPE Real Assets
- Lone Star buys €216m Dutch residential portfolio from Catella fundIPE Real Assets